Indication
Gaucher's Disease Type III
2 clinical trials
4 products
Product
VenglustatClinical trial
A Phase 3, Multicenter, Multinational, Randomized, Double-blind, Double-dummy, Active-comparator Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3 (GD3) Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ERT)Status: Recruiting, Estimated PCD: 2025-09-30
Product
imigluceraseClinical trial
Open Label, Two Cohort (With and Without Imiglucerase), Multicenter Study to Evaluate Pharmacokinetics, Safety, and Efficacy of Eliglustat in Pediatric Patients With Gaucher Disease Type 1 and Type 3Status: Active (not recruiting), Estimated PCD: 2025-11-20
Product
ImigluceraseProduct
Eliglustat